Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.

Autor: Jacobson CA; Department of medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: caron_jacobson@dfci.harvard.edu., Chavez JC; University of South Florida H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sehgal AR; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., William BM; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Munoz J; Banner MD Anderson Cancer Center, Gilbert, AZ, USA., Salles G; Department of Hematology and Medicine, Centre Hopitalier Lyon-Sud, University of Lyon, Pierre-Bénite, France., Munshi PN; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA., Casulo C; University of Rochester Medical Center, James P Wilmot Cancer Center, Rochester, NY, USA., Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., de Vos S; Ronald Reagan University of California Los Angeles Medical Center, Los Angeles, CA, USA., Reshef R; Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY, USA., Leslie LA; John Theurer Cancer Center, Hackensack, NJ, USA., Yakoub-Agha I; Centre Hospitalier Régional Universitaire de Lille, INSERM U1286, Lille, France., Oluwole OO; Vanderbilt University Medical Center, Nashville, TN, USA., Fung HCH; Fox Chase Cancer Center, Philadelphia, PA, USA., Rosenblatt J; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA., Rossi JM; Kite Pharma, Santa Monica, CA, USA., Goyal L; Kite Pharma, Santa Monica, CA, USA., Plaks V; Kite Pharma, Santa Monica, CA, USA., Yang Y; Kite Pharma, Santa Monica, CA, USA., Vezan R; Kite Pharma, Santa Monica, CA, USA., Avanzi MP; Kite Pharma, Santa Monica, CA, USA., Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2022 Jan; Vol. 23 (1), pp. 91-103. Date of Electronic Publication: 2021 Dec 08.

Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System.

Autor: Avanzi MP; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yeku O; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: yekuo@mskcc.org., Li X; Weill Cornell School of Medicine, New York, NY, USA., Wijewarnasuriya DP; Weill Cornell School of Medicine, New York, NY, USA., van Leeuwen DG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cheung K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Park H; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Purdon TJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Daniyan AF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Spitzer MH; Department of Microbiology and Immunology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Brentjens RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell School of Medicine, New York, NY, USA. Electronic address: brentjer@mskcc.org.

Publikováno v: Cell reports [Cell Rep] 2018 May 15; Vol. 23 (7), pp. 2130-2141.

A novel bioreactor and culture method drives high yields of platelets from stem cells.

Autor: Avanzi MP; New York Blood Center, New York, New York., Oluwadara OE; New York Blood Center, New York, New York., Cushing MM; Weill Cornell Medical College, New York, New York., Mitchell ML; New York Blood Center, New York, New York., Fischer S; Arteriocyte, Inc., Cleveland, Ohio., Mitchell WB; New York Blood Center, New York, New York.; Weill Cornell Medical College, New York, New York.

Publikováno v: Transfusion [Transfusion] 2016 Jan; Vol. 56 (1), pp. 170-8. Date of Electronic Publication: 2015 Oct 15.

Ex vivo production of platelets from stem cells.

Autor: Avanzi MP; Platelet Biology Laboratory, New York Blood Center, Lindsley F. Kimball Research Institute, New York, NY, USA., Mitchell WB

Publikováno v: British journal of haematology [Br J Haematol] 2014 Apr; Vol. 165 (2), pp. 237-47. Date of Electronic Publication: 2014 Feb 13.

Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesis.

Autor: Avanzi MP; Platelet Biology Laboratory, New York Blood Center, Lindsley F. Kimball Research Institute, New York, New York 10065, USA. mavanzi@nybloodcenter.org, Chen A, He W, Mitchell WB

Publikováno v: Transfusion [Transfusion] 2012 Nov; Vol. 52 (11), pp. 2406-13. Date of Electronic Publication: 2012 May 21.